Viewing StudyNCT00216203



Ignite Creation Date: 2024-05-05 @ 12:02 PM
Last Modification Date: 2024-10-26 @ 9:19 AM
Study NCT ID: NCT00216203
Status: COMPLETED
Last Update Posted: 2016-09-29
First Post: 2005-09-12

Brief Title: Pemetrexed Plus Cetuximab in Patients With Recurrent Non Small Cell Lung Cancer
Sponsor: Nasser Hanna MD
Organization: Hoosier Cancer Research Network

Organization Data

Organization: Hoosier Cancer Research Network
Class: OTHER
Study ID: HOG LUN04-79
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Nasser Hanna MD
Lead Sponsor Class: OTHER
Responsible Party: Nasser Hanna MD
Responsible Party Title: Sponsor-Investigator
Responsible Party Type: SPONSOR_INVESTIGATOR
Responsible Party Affiliation: Hoosier Cancer Research Network
Old Name: None
Old Organization: None

Collaborators

Name Class
Walther Cancer Institute OTHER
Eli Lilly and Company INDUSTRY
Bristol-Myers Squibb INDUSTRY